0001415889-21-004154.txt : 20210831 0001415889-21-004154.hdr.sgml : 20210831 20210831171811 ACCESSION NUMBER: 0001415889-21-004154 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210827 FILED AS OF DATE: 20210831 DATE AS OF CHANGE: 20210831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANE ANDREW H CENTRAL INDEX KEY: 0001643735 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 211227795 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-08312021_020857.xml X0306 4 2021-08-27 0000001800 ABBOTT LABORATORIES ABT 0001643735 LANE ANDREW H 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT Common shares without par value 2021-08-27 4 M 0 135925 38.40 A 222012 D Common shares without par value 2021-08-27 4 S 0 135925 125.475 D 86087 D Common shares without par value 1543 I Profit Sharing Trust Option (right to buy) 38.40 2021-08-27 4 M 0 135925 0 D 2019-02-19 2026-02-18 Common Shares 135925 0 D Includes shares acquired pursuant to a dividend reinvestment feature. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.96 to $125.72, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Balance in the Abbott Laboratories Stock Retirement Trust as of August 27, 2021. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). /s/ Andrew H. Lane by Jessica H. Paik, Attorney-in-Fact, Attorney-in-Fact 2021-08-31